Kidney Cancer Archives - Page 72 of 73 - Renal and Urology News

Kidney Cancer

Stereotactic Radiosurgery Beneficial

SAN DIEGO—Stereotactic radiosurgery produces early and durable responses in renal cell carcinoma (RCC) patients with either previously untreated spinal metastases or spinal metastases that have recurred after prior radiotherapy, researchers announced here at the 2007 Annual Meeting of the American Academy of Orthopedic Surgeons.

FDA Strengthens ESA Safety Information

The FDA issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs). The drugs affected by the safety update are darbepoetin alfa (Aranesp) and epoetin alfa (Epogen and Procrit).

Drugs Aid Metastatic RCC Outcomes

Two relatively new oral agents can improve outcomes for patients with metastatic renal cell carcinoma (RCC), according to recent reports. The drugs, sunitinib and sorafenib, inhibit enzymes that promote angiogenesis and thus may act by disrupting tumor vasculature.

Sorafenib Outcomes Unaffected by Age

ISTANBUL—Age does not affect clinical outcomes in sorafenib-treated patients with advanced renal cell carcinoma (RCC), researchers announced here at the 31st congress of the European Society for Medical Oncology.

CRP Predicts Worse RCC Survival

High preoperative C-reactive protein (CRP) levels are associated with worse survival in patients who undergo radical nephrectomy for localized renal cell carcinoma (RCC), according to investigators.

Next post in News